Literature DB >> 2992919

Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function.

E Y Adashi, C E Resnick, A J D'Ercole, M E Svoboda, J J Van Wyk.   

Abstract

A relatively large body of evidence now appears to support the existence of the essential ingredients for novel intraovarian IGF-driven control mechanisms. Indeed, evidence presented in this communication is in keeping with the possibility that the granulosa cell may be the site of IGF production, reception, and action. Although the relevance of IGFs to ovarian cell types other than the granulosa cell is largely unknown, one cannot at the present time exclude the possibility of nongranulosa cell contributions to intraovarian IGF production, reception, and action. Indeed, preliminary affinity cross-linking studies (Adashi, Resnick, Svoboda, Van Wyk and D'Ercole; unpublished data) suggest the existence of type-I and type-II receptors in nongranulosa cell compartments. The above notwithstanding, IGFs of granulosa (and possibly circulatory) origins may interact with granulosa cell autoreceptors either independently or in synergy with other granulosa cell agonists. According to this view, IGFs may act in the autocrine mode to stimulate granulosa cell replication on the one hand and promote granulosa cell differentiation on the other. Although proliferation and terminal differentiation may prove mutually exclusive under some circumstances, coexistence of the two processes is being increasingly recognized. In this context, some studies of porcine granulosa cells support a dual role for IGFs in granulosa cell ontogeny. As such, the IGFs can be added to a growing list of growth factors known to modulate granulosa cell growth and function, including EGF, PDGF, and FGF. Our findings indicate that Sm-C/IGF-I synergizes with FSH in the induction of rat granulosa cell aromatase activity at nanomolar concentrations compatible with its granulosa cell receptor binding affinity (thus far studied only in porcine cells. A role for Sm-C/IGF-I in the regulation of this key granulosa cell function would be in keeping with the possibility that Sm-C/IGF-I may partake in the assertion and maintenance of dominance by the selected follicle(s) or in promoting juvenile and early follicular development. Moreover, the ability of Sm-C/IGF-I to potentiate this and other FSH-driven ovarian functions may also account, at least in part, for the puberty-promoting effect of growth hormone. This permissive action of growth hormone has been initially suggested by observation in growth hormone-deficient rats, mice (dwarf mutants, and humans (sporadic, hereditary or acquired growth hormone deficiency.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2992919     DOI: 10.1210/edrv-6-3-400

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  76 in total

1.  The role of insulin-like growth factor-I (IGF-I) and estradiol in rabbit corpus luteum progesterone production.

Authors:  S H Chen; V Zanagnolo; S Preutthipan; K P Roberts; S B Goodman; A M Dharmarajan
Journal:  Endocrine       Date:  1997-02       Impact factor: 3.633

Review 2.  The insulin-like growth factor family of ligands, receptors, and binding proteins.

Authors:  R F Krywicki; D Yee
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

Review 3.  Growth factors in the ovary.

Authors:  G Giordano; A Barreca; F Minuto
Journal:  J Endocrinol Invest       Date:  1992-10       Impact factor: 4.256

Review 4.  Hirsutism: pilosebaceous unit dysregulation. Role of peripheral and glandular factors.

Authors:  V Toscano
Journal:  J Endocrinol Invest       Date:  1991-02       Impact factor: 4.256

5.  Regulation of oocyte and cumulus cell interactions by intermedin/adrenomedullin 2.

Authors:  Chia Lin Chang; Hsin-Shih Wang; Yung-Kuei Soong; Shang Yu Huang; Shun Yuan Pai; Sheau Yu Teddy Hsu
Journal:  J Biol Chem       Date:  2011-10-18       Impact factor: 5.157

6.  Persistent effects on bovine granulosa cell transcriptome after resolution of uterine disease.

Authors:  Rachel L Piersanti; Anthony D Horlock; Jeremy Block; José E P Santos; I Martin Sheldon; John J Bromfield
Journal:  Reproduction       Date:  2019-07       Impact factor: 3.906

7.  IGF-I and epidermal growth factor levels in follicular fluid of women undergoing controlled ovarian hyperstimulation using the multidose GnRH-antagonist protocol or the long GnRH-agonist protocol.

Authors:  B Asimakopoulos; B Schöpper; A Dawson; G S Caglar; I Vakalopoulos; S Al-Hasani; K Diedrich; N Nikolettos
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

8.  GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome.

Authors:  F Orio; S Palomba; A Colao; T Russo; C Dentico; L Tauchmanovà; S Savastano; C Nappi; C Sultan; F Zullo; G Lombardi
Journal:  J Endocrinol Invest       Date:  2003-02       Impact factor: 4.256

Review 9.  Nutrition, hormones, and breast cancer: is insulin the missing link?

Authors:  R Kaaks
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

10.  Is diabetes mellitus a risk factor for ovarian cancer? A case-control study in Utah and Washington (United States).

Authors:  A I Adler; N S Weiss; M L Kamb; J L Lyon
Journal:  Cancer Causes Control       Date:  1996-07       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.